View DividendUzin Utz 경영진경영진 기준 점검 2/4현재 CEO에 대한 정보가 충분하지 않습니다.핵심 정보 최고경영자n/a총 보수CEO 급여 비율n/aCEO 재임 기간no dataCEO 지분 보유율n/a경영진 평균 재임 기간3.8yrs이사회 평균 재임 기간7.3yrs최근 경영진 업데이트공고 • Apr 01+ 1 more updateUzin Utz SE, Annual General Meeting, May 13, 2026Uzin Utz SE, Annual General Meeting, May 13, 2026, at 10:30 W. Europe Standard Time.공고 • Apr 03Uzin Utz SE, Annual General Meeting, May 13, 2025Uzin Utz SE, Annual General Meeting, May 13, 2025, at 10:30 W. Europe Standard Time.공고 • Mar 29Uzin Utz SE, Annual General Meeting, May 22, 2024Uzin Utz SE, Annual General Meeting, May 22, 2024. Location: Donauhalle, Ulm Ulm Germany모든 업데이트 보기Recent updatesNew Risk • Aug 16New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. Cash payout ratio: 221% Dividend yield: 3.1% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (221% cash payout ratio). Share price has been volatile over the past 3 months (7.7% average weekly change).New Risk • Jul 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Buy Or Sell Opportunity • Jun 25Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 11% to €62.80. The fair value is estimated to be €81.98, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 8.7%. For the next 3 years, revenue is forecast to grow by 7.9% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.Valuation Update With 7 Day Price Move • Jun 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €65.20, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 42% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €90.08 per share.공고 • Apr 01+ 1 more updateUzin Utz SE, Annual General Meeting, May 13, 2026Uzin Utz SE, Annual General Meeting, May 13, 2026, at 10:30 W. Europe Standard Time.공고 • Jan 08+ 3 more updatesUzin Utz SE to Report Q3, 2026 Results on Nov 13, 2026Uzin Utz SE announced that they will report Q3, 2026 results on Nov 13, 2026공고 • Apr 04Uzin Utz SE announces Annual dividend, payable on May 16, 2025Uzin Utz SE announced Annual dividend of EUR 1.9000 per share payable on May 16, 2025, ex-date on May 14, 2025 and record date on May 15, 2025.공고 • Apr 03Uzin Utz SE, Annual General Meeting, May 13, 2025Uzin Utz SE, Annual General Meeting, May 13, 2025, at 10:30 W. Europe Standard Time.공고 • Apr 01+ 3 more updatesUzin Utz SE to Report Q1, 2025 Results on May 13, 2025Uzin Utz SE announced that they will report Q1, 2025 results on May 13, 2025Reported Earnings • Aug 18First half 2024 earnings released: EPS: €2.45 (vs €2.19 in 1H 2023)First half 2024 results: EPS: €2.45 (up from €2.19 in 1H 2023). Revenue: €242.3m (down 1.0% from 1H 2023). Net income: €12.4m (up 12% from 1H 2023). Profit margin: 5.1% (up from 4.5% in 1H 2023). Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 14% per year.Upcoming Dividend • May 16Upcoming dividend of €1.60 per shareEligible shareholders must have bought the stock before 23 May 2024. Payment date: 27 May 2024. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 3.2%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (4.9%).Price Target Changed • Apr 04Price target increased by 15% to €60.00Up from €52.00, the current price target is provided by 1 analyst. New target price is 22% above last closing price of €49.00. Stock is down 7.5% over the past year. The company is forecast to post earnings per share of €4.30 for next year compared to €4.48 last year.Reported Earnings • Mar 30Full year 2023 earnings released: EPS: €4.48 (vs €5.02 in FY 2022)Full year 2023 results: EPS: €4.48 (down from €5.02 in FY 2022). Revenue: €484.8m (flat on FY 2022). Net income: €22.6m (down 11% from FY 2022). Profit margin: 4.7% (down from 5.2% in FY 2022). Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.공고 • Mar 29Uzin Utz SE, Annual General Meeting, May 22, 2024Uzin Utz SE, Annual General Meeting, May 22, 2024. Location: Donauhalle, Ulm Ulm GermanyNew Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. This is currently the only risk that has been identified for the company.Reported Earnings • Aug 30First half 2023 earnings released: EPS: €2.19 (vs €2.68 in 1H 2022)First half 2023 results: EPS: €2.19 (down from €2.68 in 1H 2022). Revenue: €244.7m (flat on 1H 2022). Net income: €11.0m (down 19% from 1H 2022). Profit margin: 4.5% (down from 5.5% in 1H 2022). Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 5% per year and the company’s share price has also fallen by 5% per year.공고 • Jan 13+ 3 more updatesUzin Utz SE to Report Q3, 2023 Results on Nov 15, 2023Uzin Utz SE announced that they will report Q3, 2023 results on Nov 15, 2023Price Target Changed • Nov 16Price target decreased to €68.00Down from €95.00, the current price target is provided by 1 analyst. New target price is 41% above last closing price of €48.20. Stock is down 42% over the past year. The company posted earnings per share of €6.53 last year.Price Target Changed • Nov 07Price target decreased to €68.00Down from €95.00, the current price target is provided by 1 analyst. New target price is 56% above last closing price of €43.50. Stock is down 48% over the past year. The company posted earnings per share of €6.53 last year.Reported Earnings • Aug 29First half 2022 earnings released: EPS: €0 (vs €3.98 in 1H 2021)First half 2022 results: EPS: €0 (down from €3.98 in 1H 2021). Revenue: €246.5m (up 11% from 1H 2021). Net income: €13.5m (down 33% from 1H 2021). Profit margin: 5.5% (down from 9.1% in 1H 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 3.7%, compared to a 2.4% growth forecast for the Chemicals industry in Germany.Buying Opportunity • Jun 11Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 19%. The fair value is estimated to be €75.07, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.3% over the last 3 years. Earnings per share has grown by 34%.Upcoming Dividend • May 11Upcoming dividend of €1.80 per shareEligible shareholders must have bought the stock before 18 May 2022. Payment date: 20 May 2022. Trailing yield: 2.8%. Lower than top quartile of German dividend payers (4.3%). Lower than average of industry peers (5.2%).Price Target Changed • Nov 18Price target increased to €100.00Up from €89.00, the current price target is provided by 1 analyst. New target price is 21% above last closing price of €82.50. Stock is up 59% over the past year. The company posted earnings per share of €5.76 last year.Valuation Update With 7 Day Price Move • Sep 04Investor sentiment improved over the past weekAfter last week's 19% share price gain to €91.00, the stock trades at a trailing P/E ratio of 21.9x. Average forward P/E is 12x in the Chemicals industry in Germany. Total returns to shareholders of 65% over the past three years.Reported Earnings • Aug 28First half 2020 earnings released: EPS €2.01 (vs €2.14 in 1H 2019)The company reported a poor first half result with weaker earnings and profit margins, although revenues were flat. First half 2020 results: Revenue: €186.9m (flat on 1H 2019). Net income: €10.1m (down 5.9% from 1H 2019). Profit margin: 5.4% (down from 5.8% in 1H 2019).Price Target Changed • Aug 06Price target increased to €95.00Up from €85.00, the current price target is provided by 1 analyst. New target price is 28% above last closing price of €74.50. Stock is up 39% over the past year.Upcoming Dividend • May 20Upcoming dividend of €1.55 per shareEligible shareholders must have bought the stock before 27 May 2021. Payment date: 31 May 2021. Trailing yield: 1.7%. Lower than top quartile of German dividend payers (3.3%). Lower than average of industry peers (3.6%).Price Target Changed • Feb 27Price target raised to €85.00Up from €78.00, the current price target is provided by 1 analyst. The new target price is 22% above the current share price of €69.40. As of last close, the stock is up 19% over the past year.Valuation Update With 7 Day Price Move • Feb 26Investor sentiment improved over the past weekAfter last week's 16% share price gain to €69.40, the stock is trading at a trailing P/E ratio of 16.4x, up from the previous P/E ratio of 14.2x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 16%.Is New 90 Day High Low • Feb 15New 90-day high: €61.40The company is up 20% from its price of €51.00 on 17 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period.Price Target Changed • Feb 03Price target raised to €78.00Up from €70.50, the current price target is provided by 1 analyst. The new target price is 38% above the current share price of €56.40. As of last close, the stock is down 5.2% over the past year.Is New 90 Day High Low • Oct 24New 90-day low: €51.00The company is down 2.0% from its price of €52.00 on 24 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period.Is New 90 Day High Low • Sep 22New 90-day high: €56.80The company is up 4.0% from its price of €54.40 on 24 June 2020. The German market is also up 4.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 10.0% over the same period.CEOUzin Utz에는 CEO가 없거나 해당 데이터가 없습니다.리더십 팀이름직위재임 기간보수지분Julian UtzMember of Executive Board8.6yrs€494.54k4.1% € 12.9mPhilipp UtzMember of Executive Board8.6yrs€496.59k4.12% € 13.0mChristian RichterMember of Executive Board3.8yrs€381.94k데이터 없음Sandra Spruit-SpannerHead of Investor Relations2.6yrs데이터 없음데이터 없음Matthias GrafeHead of Internal Sales & Sales Management of the Groupno data데이터 없음데이터 없음Sabrina SvechlaHead of Human Resource Managementno data데이터 없음데이터 없음Matthias HofmannHead of International Group Logisticsno data데이터 없음데이터 없음Michael BachleHead of Corporate Management & SAP Applicationsno data데이터 없음데이터 없음Stefanie SeeburgerFinancial Controller & Business Partner Investor Relationsless than a year데이터 없음데이터 없음더 보기3.8yrs평균 재임 기간45yo평균 나이경험이 풍부한 관리: UZU의 경영진은 경험이 있음으로 간주됩니다(평균 재임 3.8 년).이사회 구성원이름직위재임 기간보수지분Heinz UtzChairman of the Supervisory Board10.3yrs€100.00k25.36% € 79.8mTimm WiegmannVice Chairman of the Supervisory Board7.3yrs€100.00k데이터 없음Rainer KogelMember of the Supervisory Boardno data€87.50k데이터 없음Michaela MaldonadoMember of the Supervisory Board3.3yrs€50.00k데이터 없음Amelie KlubmannMember of the Supervisory Board7.3yrs€50.00k4.13% € 13.0mSebastian DresseMember of the Supervisory Boardless than a year데이터 없음데이터 없음더 보기7.3yrs평균 재임 기간65yo평균 나이경험이 풍부한 이사회: UZU의 이사회는 경험이 있음으로 간주됩니다(평균 재임 7.3 년).View Ownership기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/18 07:42종가2026/08/18 00:00수익2026/06/30연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Uzin Utz SE는 2명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Patrick SpeckMontega AGPhilipp KaiserWarburg Research GmbH
공고 • Apr 01+ 1 more updateUzin Utz SE, Annual General Meeting, May 13, 2026Uzin Utz SE, Annual General Meeting, May 13, 2026, at 10:30 W. Europe Standard Time.
공고 • Apr 03Uzin Utz SE, Annual General Meeting, May 13, 2025Uzin Utz SE, Annual General Meeting, May 13, 2025, at 10:30 W. Europe Standard Time.
공고 • Mar 29Uzin Utz SE, Annual General Meeting, May 22, 2024Uzin Utz SE, Annual General Meeting, May 22, 2024. Location: Donauhalle, Ulm Ulm Germany
New Risk • Aug 16New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. Cash payout ratio: 221% Dividend yield: 3.1% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (221% cash payout ratio). Share price has been volatile over the past 3 months (7.7% average weekly change).
New Risk • Jul 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Buy Or Sell Opportunity • Jun 25Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 11% to €62.80. The fair value is estimated to be €81.98, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 8.7%. For the next 3 years, revenue is forecast to grow by 7.9% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.
Valuation Update With 7 Day Price Move • Jun 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €65.20, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 42% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €90.08 per share.
공고 • Apr 01+ 1 more updateUzin Utz SE, Annual General Meeting, May 13, 2026Uzin Utz SE, Annual General Meeting, May 13, 2026, at 10:30 W. Europe Standard Time.
공고 • Jan 08+ 3 more updatesUzin Utz SE to Report Q3, 2026 Results on Nov 13, 2026Uzin Utz SE announced that they will report Q3, 2026 results on Nov 13, 2026
공고 • Apr 04Uzin Utz SE announces Annual dividend, payable on May 16, 2025Uzin Utz SE announced Annual dividend of EUR 1.9000 per share payable on May 16, 2025, ex-date on May 14, 2025 and record date on May 15, 2025.
공고 • Apr 03Uzin Utz SE, Annual General Meeting, May 13, 2025Uzin Utz SE, Annual General Meeting, May 13, 2025, at 10:30 W. Europe Standard Time.
공고 • Apr 01+ 3 more updatesUzin Utz SE to Report Q1, 2025 Results on May 13, 2025Uzin Utz SE announced that they will report Q1, 2025 results on May 13, 2025
Reported Earnings • Aug 18First half 2024 earnings released: EPS: €2.45 (vs €2.19 in 1H 2023)First half 2024 results: EPS: €2.45 (up from €2.19 in 1H 2023). Revenue: €242.3m (down 1.0% from 1H 2023). Net income: €12.4m (up 12% from 1H 2023). Profit margin: 5.1% (up from 4.5% in 1H 2023). Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 14% per year.
Upcoming Dividend • May 16Upcoming dividend of €1.60 per shareEligible shareholders must have bought the stock before 23 May 2024. Payment date: 27 May 2024. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 3.2%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (4.9%).
Price Target Changed • Apr 04Price target increased by 15% to €60.00Up from €52.00, the current price target is provided by 1 analyst. New target price is 22% above last closing price of €49.00. Stock is down 7.5% over the past year. The company is forecast to post earnings per share of €4.30 for next year compared to €4.48 last year.
Reported Earnings • Mar 30Full year 2023 earnings released: EPS: €4.48 (vs €5.02 in FY 2022)Full year 2023 results: EPS: €4.48 (down from €5.02 in FY 2022). Revenue: €484.8m (flat on FY 2022). Net income: €22.6m (down 11% from FY 2022). Profit margin: 4.7% (down from 5.2% in FY 2022). Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
공고 • Mar 29Uzin Utz SE, Annual General Meeting, May 22, 2024Uzin Utz SE, Annual General Meeting, May 22, 2024. Location: Donauhalle, Ulm Ulm Germany
New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. This is currently the only risk that has been identified for the company.
Reported Earnings • Aug 30First half 2023 earnings released: EPS: €2.19 (vs €2.68 in 1H 2022)First half 2023 results: EPS: €2.19 (down from €2.68 in 1H 2022). Revenue: €244.7m (flat on 1H 2022). Net income: €11.0m (down 19% from 1H 2022). Profit margin: 4.5% (down from 5.5% in 1H 2022). Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 5% per year and the company’s share price has also fallen by 5% per year.
공고 • Jan 13+ 3 more updatesUzin Utz SE to Report Q3, 2023 Results on Nov 15, 2023Uzin Utz SE announced that they will report Q3, 2023 results on Nov 15, 2023
Price Target Changed • Nov 16Price target decreased to €68.00Down from €95.00, the current price target is provided by 1 analyst. New target price is 41% above last closing price of €48.20. Stock is down 42% over the past year. The company posted earnings per share of €6.53 last year.
Price Target Changed • Nov 07Price target decreased to €68.00Down from €95.00, the current price target is provided by 1 analyst. New target price is 56% above last closing price of €43.50. Stock is down 48% over the past year. The company posted earnings per share of €6.53 last year.
Reported Earnings • Aug 29First half 2022 earnings released: EPS: €0 (vs €3.98 in 1H 2021)First half 2022 results: EPS: €0 (down from €3.98 in 1H 2021). Revenue: €246.5m (up 11% from 1H 2021). Net income: €13.5m (down 33% from 1H 2021). Profit margin: 5.5% (down from 9.1% in 1H 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 3.7%, compared to a 2.4% growth forecast for the Chemicals industry in Germany.
Buying Opportunity • Jun 11Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 19%. The fair value is estimated to be €75.07, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.3% over the last 3 years. Earnings per share has grown by 34%.
Upcoming Dividend • May 11Upcoming dividend of €1.80 per shareEligible shareholders must have bought the stock before 18 May 2022. Payment date: 20 May 2022. Trailing yield: 2.8%. Lower than top quartile of German dividend payers (4.3%). Lower than average of industry peers (5.2%).
Price Target Changed • Nov 18Price target increased to €100.00Up from €89.00, the current price target is provided by 1 analyst. New target price is 21% above last closing price of €82.50. Stock is up 59% over the past year. The company posted earnings per share of €5.76 last year.
Valuation Update With 7 Day Price Move • Sep 04Investor sentiment improved over the past weekAfter last week's 19% share price gain to €91.00, the stock trades at a trailing P/E ratio of 21.9x. Average forward P/E is 12x in the Chemicals industry in Germany. Total returns to shareholders of 65% over the past three years.
Reported Earnings • Aug 28First half 2020 earnings released: EPS €2.01 (vs €2.14 in 1H 2019)The company reported a poor first half result with weaker earnings and profit margins, although revenues were flat. First half 2020 results: Revenue: €186.9m (flat on 1H 2019). Net income: €10.1m (down 5.9% from 1H 2019). Profit margin: 5.4% (down from 5.8% in 1H 2019).
Price Target Changed • Aug 06Price target increased to €95.00Up from €85.00, the current price target is provided by 1 analyst. New target price is 28% above last closing price of €74.50. Stock is up 39% over the past year.
Upcoming Dividend • May 20Upcoming dividend of €1.55 per shareEligible shareholders must have bought the stock before 27 May 2021. Payment date: 31 May 2021. Trailing yield: 1.7%. Lower than top quartile of German dividend payers (3.3%). Lower than average of industry peers (3.6%).
Price Target Changed • Feb 27Price target raised to €85.00Up from €78.00, the current price target is provided by 1 analyst. The new target price is 22% above the current share price of €69.40. As of last close, the stock is up 19% over the past year.
Valuation Update With 7 Day Price Move • Feb 26Investor sentiment improved over the past weekAfter last week's 16% share price gain to €69.40, the stock is trading at a trailing P/E ratio of 16.4x, up from the previous P/E ratio of 14.2x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 16%.
Is New 90 Day High Low • Feb 15New 90-day high: €61.40The company is up 20% from its price of €51.00 on 17 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period.
Price Target Changed • Feb 03Price target raised to €78.00Up from €70.50, the current price target is provided by 1 analyst. The new target price is 38% above the current share price of €56.40. As of last close, the stock is down 5.2% over the past year.
Is New 90 Day High Low • Oct 24New 90-day low: €51.00The company is down 2.0% from its price of €52.00 on 24 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period.
Is New 90 Day High Low • Sep 22New 90-day high: €56.80The company is up 4.0% from its price of €54.40 on 24 June 2020. The German market is also up 4.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 10.0% over the same period.